Results 121 to 130 of about 170,816 (168)

Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity

Cancer Cell, 2021
Andrew Chow, Sara Schad, Michael D Green   +2 more
exaly  

TIM-3: An update on immunotherapy

International Immunopharmacology, 2021
Lizhen Zhao, Shaoyun Cheng, Lin Fan
exaly  

Spatial distribution and functional analysis define the action pathway of Tim-3/Tim-3 ligands in tumor development

Molecular Therapy, 2022
Tixiao Wang
exaly  

Tim

2022
Hameeda Lakho, Jeroen Wapenaar
openaire   +1 more source

The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake

Immunity, 2021
Alvaro De Mingo Pulido, Kay Hänggi, Daiana P Celias   +2 more
exaly  

TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory

Cancer Cell, 2023
Lucia Marrodan, Sandra Laternser, Jasper Van Der Lugt   +2 more
exaly  

Tim

2023
openaire   +1 more source

Dim Dim, Tim Tim

Ghana Studies, 2009
openaire   +1 more source

Dim Dim, Tim Tim

Ghana Studies, 2011
openaire   +1 more source

TIM-3 Regulates CD103+ Dendritic Cell Function and Response to Chemotherapy in Breast Cancer

Cancer Cell, 2018
Alvaro De Mingo Pulido, Alycia Gardner, Hatem Soliman   +2 more
exaly